ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 84 filers reported holding ATHIRA PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $40,878 | -82.8% | 13,857 | -85.4% | 0.00% | – |
Q1 2023 | $237,743 | -15.5% | 95,097 | +7.1% | 0.00% | – |
Q4 2022 | $281,502 | +6.6% | 88,802 | 0.0% | 0.00% | – |
Q3 2022 | $264,000 | -2.6% | 88,802 | 0.0% | 0.00% | – |
Q2 2022 | $271,000 | -76.5% | 88,802 | +4.0% | 0.00% | – |
Q1 2022 | $1,153,000 | +4.6% | 85,397 | +1.0% | 0.00% | – |
Q4 2021 | $1,102,000 | +43.7% | 84,550 | +3.4% | 0.00% | – |
Q3 2021 | $767,000 | -50.7% | 81,765 | -46.2% | 0.00% | -100.0% |
Q2 2021 | $1,557,000 | -24.0% | 151,986 | +36.6% | 0.00% | 0.0% |
Q1 2021 | $2,048,000 | -28.6% | 111,268 | +32.9% | 0.00% | 0.0% |
Q4 2020 | $2,869,000 | – | 83,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |